Skip to menu Skip to content Skip to footer

2016

Journal Article

Interleukin 6 promoter 174 G/C polymorphisms in acute ischemic stroke: G allele is protective but not associated with IL-6 levels or stroke outcome

Yan, J., Greer, J. M. and McCombe, P. A. (2016). Interleukin 6 promoter 174 G/C polymorphisms in acute ischemic stroke: G allele is protective but not associated with IL-6 levels or stroke outcome. Journal of Neuroimmunology, 293, 22-27. doi: 10.1016/j.jneuroim.2016.02.001

Interleukin 6 promoter 174 G/C polymorphisms in acute ischemic stroke: G allele is protective but not associated with IL-6 levels or stroke outcome

2016

Journal Article

Contribution of different relapse phenotypes to disability in multiple sclerosis

Stewart, Tamasine, Spelman, Tim, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Shaygannejad, Vahid, Hupperts, Raymond, Alroughani, Raed, Oreja-Guevara, Celia, Pucci, Eugenio, Boz, Cavit, Lechner-Scott, Jeannette, Bergamaschi, Roberto, Van Pesch, Vincent, Iuliano, Gerardo, Ramo, Cristina, Taylor, Bruce, Slee, Mark, Spitaleri, Daniele, Granella, Franco, Verheul, Freek ... Kalincik, Tomas (2016). Contribution of different relapse phenotypes to disability in multiple sclerosis. Multiple Sclerosis Journal, 23 (2), 266-276. doi: 10.1177/1352458516643392

Contribution of different relapse phenotypes to disability in multiple sclerosis

2016

Journal Article

A case series of patients with autoimmune myasthenia gravis in association with invasive thymoma

McCombe, Pamela, Raj, Meenakshi, Henderson, Robert and Blum, Stefan (2016). A case series of patients with autoimmune myasthenia gravis in association with invasive thymoma. Journal of Clinical Neuromuscular Disease, 17 (3), 129-134. doi: 10.1097/CND.0000000000000101

A case series of patients with autoimmune myasthenia gravis in association with invasive thymoma

2015

Journal Article

Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis

Devine, Matthew S., Ballard, Emma, O'Rourke, Peter, Kiernan, Matther C., Mccombe, Pamela A. and Henderson, Robert D. (2015). Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17 (3-4), 1-7. doi: 10.3109/21678421.2015.1125502

Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis

2015

Journal Article

Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis

Ngo, S. T., Steyn, F. J., Huang, L., Mantovani, S., Pfluger, C. M. M., Woodruff, T. M., O'Sullivan, J. D., Henderson, R. D. and McCombe, P. A. (2015). Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 357 (1-2), 22-27. doi: 10.1016/j.jns.2015.06.053

Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis

2015

Journal Article

Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome

Chan, Adeline, Yan, Jun, Csurhes, Peter, Greer, Judith and McCombe, Pamela (2015). Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome. Journal of Neuroimmunology, 286, 42-47. doi: 10.1016/j.jneuroim.2015.06.013

Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome

2015

Journal Article

When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms

Ioannides, Z. A., Henderson, R. D., Robertson, T., Davis, M. and McCombe, P. A. (2015). When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms. Journal of Neurology, Neurosurgery and Psychiatry, 87 (9), 1031-1032. doi: 10.1136/jnnp-2015-311582

When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms

2015

Journal Article

A new era in the treatment of multiple sclerosis

Broadley, Simon A., Barnett, Michael H., Boggild, Mike, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith M., Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., King, John, McCombe, Pamela A., Pollard, John D. and Willoughby, Ernest (2015). A new era in the treatment of multiple sclerosis. Medical Journal of Australia, 203 (3), 139-141e.1. doi: 10.5694/mja14.01218

A new era in the treatment of multiple sclerosis

2015

Journal Article

The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in

Blum, Stefan, Csurhes, Peter and McCombe, Pamela (2015). The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in. Journal of Neuroimmunology, 285, 53-56. doi: 10.1016/j.jneuroim.2015.05.017

The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in

2015

Journal Article

Clinical features and impact of myasthenia gravis disease in Australian patients

Blum, Stefan, Lee, David, Gillis, David, McEniery, David F., Reddel, Stephen and McCombe, Pamela (2015). Clinical features and impact of myasthenia gravis disease in Australian patients. Journal of Clinical Neuroscience, 22 (7), 1164-1169. doi: 10.1016/j.jocn.2015.01.022

Clinical features and impact of myasthenia gravis disease in Australian patients

2015

Journal Article

Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis

McCombe, P. A., Pfluger, C., Singh, P., Lim, C. Y. H., Airey, C. and Henderson, R. D. (2015). Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 353 (1-2), 122-129. doi: 10.1016/j.jns.2015.04.032

Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis

2015

Journal Article

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

Kalincik, Tomas, Horakova, Dana, Spelman, Tim, Jokubaitis, Vilija, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Rozsa, Csilla, Grammond, Pierre, Alroughani, Raed, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Lechner-Scott, Jeannette, Slee, Mark, Fernandez-Bolanos, Ricardo, Grand'Maison, Francois, Hupperts, Raymond, Verheul, Freek, Hodgkinson, Suzanne, Oreja-Guevara, Celia, Spitaleri, Daniele, Barnett, Michael, Terzi, Murat, Bergamaschi, Roberto, McCombe, Pamela, Sanchez-Menoyo, Jose, Simo Magdolna, Csepany, Tunde ... and on behalf of the MSBase Study Group (2015). Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis. Annals of Neurology, 77 (3), 425-435. doi: 10.1002/ana.24339

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

2015

Journal Article

Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis

Devine, Matthew S., Pannek, Kerstin, Coulthard, Alan, McCombe, Pamela A., Rose, Stephen E. and Henderson, Robert D. (2015). Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis. NeuroImage: Clinical, 7, 782-787. doi: 10.1016/j.nicl.2015.03.006

Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis

2015

Journal Article

Female infertility and multiple sclerosis: is this an issue?

McCombe, Pamela A. and Stenager, Egon (2015). Female infertility and multiple sclerosis: is this an issue?. Multiple Sclerosis Journal, 21 (1), 5-7. doi: 10.1177/1352458514549406

Female infertility and multiple sclerosis: is this an issue?

2014

Journal Article

Study of motor asymmetry in ALS indicates an effect of limb dominance on onset and spread of weakness, and an important role for upper motor neurons

Devine, Matthew S., Kiernan, Matthew C., Heggie, Susan, McCombe, Pamela A. and Henderson, Robert D. (2014). Study of motor asymmetry in ALS indicates an effect of limb dominance on onset and spread of weakness, and an important role for upper motor neurons. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15 (7-8), 481-487. doi: 10.3109/21678421.2014.906617

Study of motor asymmetry in ALS indicates an effect of limb dominance on onset and spread of weakness, and an important role for upper motor neurons

2014

Journal Article

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies

Broadley, Simon A., Barnett, Michael H., Boggild, Mike, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G. i, Lechner-Scott, Jeannette, Macdonell, Richard A. L., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., King, John, McCombe, Pamela A., Pollard, John D. and Willoughby, Ernest (2014). Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies. Journal of Clinical Neuroscience, 21 (11), 1835-1846. doi: 10.1016/j.jocn.2014.01.016

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies

2014

Journal Article

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists

Broadley, Simon A, Barnett, Michael H, Boggild, Mike, Brew, Bruce J, Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G, Lechner-Scott, Jeannette, Macdonell, Richard A L, Marriott, Mark, Mason, Deborah F, Parratt, John, Reddel, Stephen W, Shaw, Cameron P, Slee, Mark, Spies, Judith, Taylor, Bruce V, Carroll, William M, Kilpatrick, Trevor J, King, John, McCombe, Pamela A, Pollard, John D, Willoughby, Ernest and MS Neurology Group of the Australian and New Zealand Association of Neurologists (2014). Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists. Journal of Clinical Neuroscience, 21 (11), 1847-1856. doi: 10.1016/j.jocn.2014.01.018

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists

2014

Journal Article

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective - part 3: treatment practicalities and recommendations

Broadley, Simon A., Barnett, Michael H., Boggild, Mike, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., King, John, McCombe, Pamela A., Pollard, John D. and Willoughby, Ernest (2014). Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective - part 3: treatment practicalities and recommendations. Journal of Clinical Neuroscience, 21 (11), 1857-1865. doi: 10.1016/j.jocn.2014.01.017

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective - part 3: treatment practicalities and recommendations

2014

Journal Article

Multiparity in women with multiple sclerosis causes less long-term disability: No

McCombe, P. A. and Callaway, L. K. (2014). Multiparity in women with multiple sclerosis causes less long-term disability: No. Multiple Sclerosis Journal, 20 (11), 1435-1436. doi: 10.1177/1352458514541979

Multiparity in women with multiple sclerosis causes less long-term disability: No

2014

Journal Article

Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood

Mantovani, S., Gordon, R., Macmaw, J. K., Plfluger, C. M., Henderson, R. D., Noakes, P. G., McCombe, P. A. and Woodruff, T. M. (2014). Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood. Journal of Neuroimmunology, 276 (1-2), 213-218. doi: 10.1016/j.jneuroim.2014.09.005

Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood